Evidence map›Paper›PMID 30611196›Full record

Observational studyBMC cardiovascular disorders2019

Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure.

Viera Stubnova, Ingrid Os, Aud Høieggen, Marit D Solbu, Morten Grundtvig, Arne S Westheim, Dan Atar, Bård Waldum-Grevbo

Abstract readComparative StudyObservational Study
In one paragraph

Observational study in BMC cardiovascular disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Viera StubnovaFinnmark Hospital Trust, Kirkenes, Norway. viera.stubnova@medisin.uio.no.ORCID 0000-0003-3923-4843
Ingrid OsInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Aud HøieggenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Marit D SolbuSection of Nephrology, University Hospital of North Norway, Tromsø, Norway.
Morten GrundtvigDepartment of Medicine, Innlandet Hospital Trust, Lillehammer, Norway.
Arne S WestheimDepartment of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway.
Dan AtarInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Bård Waldum-GrevboDepartment of Nephrology, Oslo University Hospital, Ullevål, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElevated serum uric acid (SUA) is associated with poor prognosis in patients with cardiovascular disease, yet it is still not decided whether the role of SUA is causal or only reflects an underlying disease. The purpose of the study was to investigate if SUA was an independent predictor of 5-year all-cause mortality in a propensity score matched cohort of chronic heart failure (HF) outpatients. Furthermore, to assess whether gender or renal function modified the effect of SUA.

methodsPatients (n = 4684) from the Norwegian Heart Failure Registry with baseline SUA were included in the study. Individuals in the highest gender-specific SUA quartile were propensity score matched 1:1 with patients in the lowest three SUA quartiles. The propensity score matching procedure created 928 pairs of patients (73.4% males, mean age 71.4 ± 11.5 years) with comparable baseline characteristics. Kaplan Meier and Cox regression analyses were used to investigate the independent effect of SUA on all-cause mortality.

resultsSUA in the highest quartile was an independent predictor of all-cause mortality in HF outpatients (hazard ratio (HR) 1.19, 95% confidence interval (CI) 1.03-1.37, p-value 0.021). Gender was found to interact the relationship between SUA and all-cause mortality (p-value for interaction 0.007). High SUA was an independent predictor of all-cause mortality in women (HR 1.65, 95% CI 1.24-2.20, p-value 0.001), but not in men (HR 1.06, 95% CI 0.89-1.25, p-value 0.527). Renal function did not influence the relationship between SUA and all-cause mortality (p-value for interaction 0.539).

conclusionsHigh SUA was independently associated with inferior 5-year survival in Norwegian HF outpatients. The finding was modified by gender and high SUA was only an independent predictor of 5-year all-cause mortality in women, not in men.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersCause of DeathChronic DiseaseFemaleHeart FailureHumansHyperuricemiaMaleMiddle AgedNorwayPrognosisRegistriesBiomarkersUric AcidAll-cause mortalityEpidemiologyGenderHeart failureKidney diseasePropensity scoreUric acid

Identifiers

PMID30611196
PMCPMC6321661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.